Cargando…

Current status of therapeutic approaches and vaccines for SARS-CoV-2

SARS-CoV-2, declared a pandemic in March 2020, is the current global health challenge. The global bioburden of this virus is increasing at a rapid pace. Many antiviral drugs and vaccines have been registered for clinical trials because of their inhibitory activity observed in vitro. Currently, five...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wahid, Braira, Amir, Anam, Ameen, Ayesha, Idrees, Muhammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Special Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582592/ https://www.ncbi.nlm.nih.gov/pubmed/34758638 http://dx.doi.org/10.2217/fmb-2020-0147

Ejemplares similares

The History and Current Killings of Polio Vaccinators in Pakistan: A Need for Targeted Surveillance Strategy
por: Wahid, Braira, et al.
Publicado: (2023)

Molecular epidemiology of SARS-CoV-2 in Faisalabad, Pakistan: A real-world clinical experience
por: Raza, Hassan, et al.
Publicado: (2020)

New Insights into the Epigenetics of Hepatocellular Carcinoma
por: Wahid, Braira, et al.
Publicado: (2017)

Immunotherapeutic strategies for sexually transmitted viral infections: HIV, HSV and HPV
por: Wahid, Braira, et al.
Publicado: (2016)

SARS-CoV-2 Variants and Vaccines
por: Krause, Philip R., et al.
Publicado: (2021)

Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics
por: Kandimalla, Ramesh, et al.
Publicado: (2020)

SARS-CoV-2 Vaccine Development: Current Status
por: Poland, Gregory A., et al.
Publicado: (2020)

Forensic case-work analysis and legal challenges during pandemic: an update from Pakistan
por: Wahid, Braira
Publicado: (2020)

Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines()
por: Sánchez-Álvarez, Emilio, et al.
Publicado: (2021)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Is there any effect of flu vaccine on the SARS-CoV-2 infected patients?
por: El-Qutob, D., et al.
Publicado: (2022)

Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis
por: Riaz, Hafiza Arooba, et al.
Publicado: (2023)

Correction: Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2022)

Evidence-Based Guidelines for SARS-COV-2 Vaccination of Patients of Skin Allergic Diseases and Patients on Immuno-Therapeutics
por: Das, Anupam, et al.
Publicado: (2022)

August 2021 and the Delta variant: is mandatory vaccination of individuals against SARS-CoV-2 acceptable?()
por: Dal-Ré, Rafael, et al.
Publicado: (2022)

SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility
por: Morris, Randy S.
Publicado: (2021)

SARS-CoV-2 placentitis, stillbirth, and maternal COVID-19 vaccination: clinical–pathologic correlations
por: Schwartz, David A., et al.
Publicado: (2023)

Developing a deeper insight into reproductive biomarkers
por: Wahid, Braira, et al.
Publicado: (2017)

SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19
por: Liang, Hong-Yu, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
por: Ali, Amjad, et al.
Publicado: (2023)

SARS-CoV-2 vaccine testing and trials in the pediatric population: biologic, ethical, research, and implementation challenges
por: Cooper, Dan M., et al.
Publicado: (2021)

Relevance of immune response and vaccination strategies of SARS-CoV-2 in the phase of viral red queen dynamics
por: Jacob, Jobin John, et al.
Publicado: (2021)

Myocarditis related SARS-CoV-2 infection or vaccination: an expert consensus statement on its diagnosis and management
por: Barreiro-Pérez, Manuel, et al.
Publicado: (2023)

Air contamination with SARS-CoV-2 in the operating room
por: Hirota, Kazuyoshi
Publicado: (2020)

Are the COVID-19’s vaccines efficient on the most dangerous variant of SARS-CoV-2?
por: Davoodi, Poorya, et al.
Publicado: (2021)

Current Potential Therapeutic Approaches against SARS-CoV-2: A Review
por: Yadav, Dharmendra Kumar, et al.
Publicado: (2021)

Bioinformatical study on the proteomics and evolution of SARS-CoV
por: Liu, Shuqun, et al.
Publicado: (2003)

Tocilizumab in patients infected by SARS-CoV2()
por: Sancho, Milagros, et al.
Publicado: (2021)

Therapeutische Nanobodies gegen SARS-CoV-2
por: Güttler, Thomas, et al.
Publicado: (2022)

Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
por: Awadasseid, Annoor, et al.
Publicado: (2021)

Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy
por: Fani, Mona, et al.
Publicado: (2023)

Interpretation of laboratory tests for prevention of the SARS-CoV-2 transmission
por: Masui, Kenichi
Publicado: (2020)

SARS-CoV-2 Vaccines: Status Report
por: Amanat, Fatima, et al.
Publicado: (2020)

Control of SARS-CoV-2 transmission in orthodontic practice
por: Guo, Yongwen, et al.
Publicado: (2020)

The interplay of SARS-CoV-2 and Clostridioides difficile infection
por: Khanna, Sahil, et al.
Publicado: (2021)

A systematic review of current status and challenges of vaccinating children against SARS-CoV-2
por: Zhang, Mengxin, et al.
Publicado: (2022)

SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
por: Syahniar, Rike, et al.
Publicado: (2022)

Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
por: Essa, Raahilah Zahir, et al.
Publicado: (2022)

Cell and animal models of SARS-CoV-2 pathogenesis and immunity
por: Leist, Sarah R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1tshn09qceui8luu3rga2lh4v6